Patent layout
MicroFlux is our proprietary first-generation transcatheter device for the treatment of HFpEF. It works by creating a small opening in the atrial septum, and once MicroFlux is deployed, it forms a passage between the left and the right atrium that enables the left atrium to decompress at rest and physical activity, with the aim of lowering left atrial pressure.
MicroFlux立体支架结构设计可适应各种生理结构的心房间隔;附于器械上的特殊覆膜可避免血栓性事件,并为二次手术预留空间;输送导管系统可于手术过程中或手术后随时将MicroFlux收回,从而提高手术安全性。
Application No | Patent name | Application Type | State |
201922261026.2 | 一种可控释放的系统 | 实用新型 | 授权 |